BACKGROUND

Gallbladder cancer (GBC) is the most common cancer of the biliary tract, but molecularly targeted therapies are not available for GBC. Loss of microRNA (miR)-335 expression may be a useful predictor of clinical outcomes and the reversal of its loss of expression may be a useful treatment strategy for GBC. In this study, we investigated whether a long noncoding RNA, nuclear paraspeckle assembly transcript 1 () sponges in GBC cells.

MATERIALS AND METHODS

Quantitative reverse transcription-polymerase chain reaction (qRT-PCR), Western blotting, and immunohistochemistry were used to determine the expression of ; survivin; and in GBC cell lines (GBC-SD and SGC-996) and tissue samples from patients (n = 25). Cell Counting Kit-8, colony-formation, and Transwell migration and invasion assays were performed to measure cell proliferation, migration, and invasion. Bioinformatic analysis and dual-luciferase reporter assays were utilized to analyze correlativity.

RESULTS

overexpression resulted in inhibition of GBC cell proliferation and invasion. In addition, knockdown of resulted in downregulation of survivin expression. As competitively "sponges" knockdown resulted in inhibited GBC cell proliferation and invasion in vitro and GBC tumor growth in vivo. Furthermore, was found to be upregulated in GBC samples, and its expression was inversely correlated with levels, but positively correlated with survivin levels.

CONCLUSION

These findings indicate that promotes survivin expression by functioning as a competitive endogenous RNA for in GBC cells; thus, we have identified a potential biomarker and target for GBC diagnosis and therapy.